Fortis Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.2M Buy
9,311
+472
+5% +$482K 1.25% 21
2026
Q1
$8.13M Buy
8,839
+114
+1% +$116K 0.83% 24
2025
Q4
$9.38M Buy
8,725
+458
+6% +$438K 1.24% 20
2025
Q3
$6.31M Buy
8,267
+7,843
+1,850% +$5.84M 0.89% 34
2025
Q2
$330K Buy
424
+139
+49% +$108K 0.05% 128
2025
Q1
$236K Buy
+285
New +$237K 0.05% 132
2020
Q4
Sell
-14,000
Closed -$2.07M 117
2020
Q3
$2.07M Buy
+14,000
New +$2.17M 1.65% 10

Other funds holding LLY

Fortis Capital Management's LLY Position: Q2 2026 in Review

Fortis Capital Management increased its Eli Lilly (LLY) stake by 5.3% in Q2 2026, buying an estimated $482K and bringing the position to 9,311 shares worth $11.2M. The position accounts for 1.25% of the portfolio, ranked #21.

Fortis Capital Management first reported a position in LLY in Q3 2020 and has held it in 7 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fortis Capital Management held 9,311 shares of Eli Lilly worth $11.2M as of Q2 2026.
  • Fortis Capital Management bought 472 Eli Lilly shares in Q2 2026, an estimated $482K.
  • Eli Lilly made up 1.25% of Fortis Capital Management's portfolio in Q2 2026, its #21 holding.
  • Fortis Capital Management first reported a position in Eli Lilly in Q3 2020 and has held it in 7 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fortis Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.